NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $255,363 | +0.9% | 2,507 | 0.0% | 0.17% | -0.6% |
| Q2 2023 | $252,981 | +9.7% | 2,507 | 0.0% | 0.17% | -4.9% |
| Q1 2023 | $230,644 | +1.1% | 2,507 | -0.3% | 0.18% | -16.4% |
| Q4 2022 | $228,070 | +7.1% | 2,514 | 0.0% | 0.22% | +4.8% |
| Q2 2022 | $213,000 | -3.6% | 2,514 | 0.0% | 0.21% | +11.8% |
| Q1 2022 | $221,000 | +0.5% | 2,514 | 0.0% | 0.19% | -2.6% |
| Q4 2021 | $220,000 | – | 2,514 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |